~~<i id='714CC71A5D'><strike id='714CC71A5D'><tt id='714CC71A5D'><pre id='714CC71A5D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：hotspot 2025-10-09 06:45:49 - browse：696

A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat — PATRICK T. FALLON/AFP via Getty Images

You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

He had a point.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Shifting the focus from loneliness to social health

knowledge

hotspot

focus

knowledge

hotspot

knowledge

AdobeForadecade,leadingacademicinstitutesandtheirassociatedcompaniesfoughtabruising,headline-grabbin

WSS

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

NIH documents show early flaws of $1.6 billion long Covid program

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Readout Newsletter: The latest on Moderna, Apellis, and Merck

entertainment

entertainment

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Letters to First Opinion on caregivers, digital health, and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What STAT readers think about the FDA and patient advocacy

Alkermes shareholders re

NIH documents show early flaws of $1.6 billion long Covid program

Guidelines to prevent youth baseball injuries need more muscle

Shifting the focus from loneliness to social health

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare Advantage beneficiaries sue Humana over algorithm use

hotspot

Virtual care provider acquires bankrupt Pear's prescription apps

The Pandemic Treaty must support building strong health systems

FDA's Pazdur wants cancer trials to range beyond China alone

Cord blood banking comes at a high cost to babies

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Readout Newsletter: The latest on Moderna, Apellis, and Merck

focus

knowledge

hotspot

knowledge